New Alzheimer's Drug Cuts Cognitive Decline by 54%

getfile.aspx

An experimental Alzheimer's drug given just twice a year slowed cognitive decline by 54% in patients with early-stage disease, raising hopes for a powerful new treatment that could help millions preserve their memory and independence. The findings, presented this week at the...

Continue reading...

[ H/T Newsmax ]
  • Reading time 1 min read
  • Reading time 1 min read
  • Reading time 1 min read
  • Reading time 1 min read
  • Reading time 1 min read
  • Reading time 1 min read

Comments

There are no comments to display
Back
Top